Distribution and Current State of Molecular Genetic Characterization in Pathogenic Free-Living Amoebae.
Alejandro Otero-RuizLeobardo Daniel Gonzalez-ZuñigaLibia Zulema Rodriguez-AnayaLuis Fernando Lares-JiménezJose Reyes Gonzalez-GalavizFernando Lares-VillaPublished in: Pathogens (Basel, Switzerland) (2022)
Free-living amoebae (FLA) are protozoa widely distributed in the environment, found in a great diversity of terrestrial biomes. Some genera of FLA are linked to human infections. The genus Acanthamoeba is currently classified into 23 genotypes (T1-T23), and of these some (T1, T2, T4, T5, T10, T12, and T18) are known to be capable of causing granulomatous amoebic encephalitis (GAE) mainly in immunocompromised patients while other genotypes (T2, T3, T4, T5, T6, T10, T11, T12, and T15) cause Acanthamoeba keratitis mainly in otherwise healthy patients. Meanwhile, Naegleria fowleri is the causative agent of an acute infection called primary amoebic meningoencephalitis (PAM), while Balamuthia mandrillaris , like some Acanthamoeba genotypes, causes GAE, differing from the latter in the description of numerous cases in patients immunocompetent. Finally, other FLA related to the pathologies mentioned above have been reported; Sappinia sp. is responsible for one case of amoebic encephalitis; Vermamoeba vermiformis has been found in cases of ocular damage, and its extraordinary capacity as endocytobiont for microorganisms of public health importance such as Legionella pneumophila, Bacillus anthracis , and Pseudomonas aeruginosa , among others. This review addressed issues related to epidemiology, updating their geographic distribution and cases reported in recent years for pathogenic FLA.
Keyphrases
- end stage renal disease
- public health
- ejection fraction
- newly diagnosed
- chronic kidney disease
- pseudomonas aeruginosa
- peritoneal dialysis
- prognostic factors
- oxidative stress
- rheumatoid arthritis
- risk factors
- intensive care unit
- staphylococcus aureus
- hepatitis b virus
- acinetobacter baumannii
- induced pluripotent stem cells